Status
Conditions
About
Purpose: To confirm the changes in lifestyle due to differences in perceptions of infectious disease risk after the COVID-19 pandemic, decrease in exposure levels of environmentally hazardous chemicals and changes in indicators related to chronic kidney disease
Methods:
Clinical endpoints:
Statistical methods: chi-square test, independent mean comparison t-test, ANOVA test, regression analysis
Full description
Background In daily life, people are exposed to various environmental hormones (Endocrine Disrupting Chemicals) such as phthalates, bisphenols, heavy metals, and perfluorinated compounds. Due to the recent pandemic of the COVID-19, behavior patterns such as wearing a mask and refraining from going out in daily life have changed. Such behavioral changes have the potential to change the level of exposure to environmental hazards, like intervention studies. In addition, studies have been reported that exposure to various environmental hormones can affect kidney function, but epidemiological studies are insufficient. Therefore, the research team is trying to determine whether exposure to environmental hormones changes due to changes in behavioral patterns according to the new corona epidemic, and to determine the effect on renal function indices in patients with chronic kidney disease.
Hypothesis and Purpose
Methods (1) During the COVID-19 pandemic
Acquisition of consent (using explanations and posters) by explaining the research purpose and method
Survey on changes in awareness of diseases and changes in hygiene activities since the COVID-19 pandemic compared to before
Measurement of the concentration of environmentally hazardous substances through the acquisition of blood (serum, residual samples after blood tests for treatment) and urine samples that are normally performed in the office (3 months cycle, 4 times)
Acquisition of clinical information related to kidney disease (2) Recovery period of the COVID-19 pandemic
Survey on changes in awareness of diseases and hygiene activities that have changed since the end of the COVID-19 outbreak
Measurement of the concentration of environmentally harmful substances by obtaining blood (serum, residual sample after blood test for medical treatment) and urine sample (once after 6 months of termination)
Acquisition of clinical information related to kidney disease (3) Investigation variable
a) Survey
Demographic information
Anthropometric information
Risk perception for the COVID-19
Individual behavior associated with hygiene
Social distancing pattern b) Chemical material in human sample (blood, urine)
Phthalate metabolite
Paraben metabolite
Benzophenone
Triclosan and triclocarban
Bisphenols
Phosphate metabolites
Organochlorine pesticides
Polychlorinated biphenyls c) Clinical information including estimated glomerular filtration rate, urine protein/creatinine ratio
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Jung Pyo Lee, M.D., Ph.D; Jeonghwan Lee, Dr.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal